Hillsdale Investment Management Inc. lessened its stake in Dolby Laboratories (NYSE:DLB – Free Report) by 44.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,800 shares of the electronics maker’s stock after selling 10,900 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Dolby Laboratories were worth $886,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Hantz Financial Services Inc. boosted its stake in Dolby Laboratories by 166.7% in the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after acquiring an additional 220 shares during the last quarter. Rothschild Investment LLC boosted its stake in Dolby Laboratories by 4,046.7% in the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after acquiring an additional 607 shares during the last quarter. Fifth Third Bancorp boosted its stake in Dolby Laboratories by 34.7% in the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares during the last quarter. Optiver Holding B.V. boosted its stake in Dolby Laboratories by 7,955.6% in the third quarter. Optiver Holding B.V. now owns 725 shares of the electronics maker’s stock valued at $52,000 after acquiring an additional 716 shares during the last quarter. Finally, Aquatic Capital Management LLC bought a new position in Dolby Laboratories in the third quarter valued at approximately $56,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Insider Activity at Dolby Laboratories
In related news, CMO Todd Pendleton sold 11,876 shares of the firm’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $54.55, for a total transaction of $647,835.80. Following the sale, the chief marketing officer directly owned 41,480 shares in the company, valued at $2,262,734. This trade represents a 22.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP John D. Couling sold 7,666 shares of the firm’s stock in a transaction on Tuesday, May 5th. The stock was sold at an average price of $57.55, for a total transaction of $441,178.30. Following the sale, the senior vice president owned 118,353 shares in the company, valued at approximately $6,811,215.15. The trade was a 6.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 32,125 shares of company stock valued at $1,805,270. Insiders own 37.93% of the company’s stock.
Dolby Laboratories Price Performance
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. During the same quarter in the previous year, the business posted $1.34 EPS. Dolby Laboratories’s revenue for the quarter was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts expect that Dolby Laboratories will post 3.21 earnings per share for the current year.
Dolby Laboratories Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date was Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 56.92%.
Analyst Ratings Changes
DLB has been the topic of a number of recent research reports. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, April 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Finally, Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.
Check Out Our Latest Stock Report on DLB
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
